P.L. 111-148 Affordable Care Act, modifications
Prior authorization utilization policies
Medicare Access and CHIP Reauthorization Act (P.L. 114-10) Improvement Issues
Medicare Physician Payment Issues
Drug Pricing and Shortages Issues
Medicare Part B Drug Price Issues
Expansion of Telehealth Services
Vision Research Funding
Implementation of No Surprises Act
The Improving Seniors' Timely Access to Care Act
S. 652/H.R. 2630, the Safe Step Act
The Ensuring Lasting Smiles Act
Medicare Coverage for Low Vision Devices
S. 1573/H.R. 3226 - Preemie Reauthorization Act of 2023
H.R.2474 - Strengthening Medicare for Patients and Providers Act
Healthcare Workforce Issues
H.R. 6545, the Physician Fee Schedule Update and Improvements Act
H.R. 6683, the Preserving Seniors Access to Physicians Act of 2023
H.R. 6487/S. 3805, the No Fees for EFTs Act
H.R. 4968, the GOLD CARD Act
H.R. 830/S. 1375, the Help Ensure Lower Patient Copays Act (HELP Copays Act)
H.R. 2748, the Contact Lens Prescription Verification Modernization Act
H.R. 1503, the Prescription Information Modernization Act of 2023
H.R. 7745, the Embracing Anti-Discrimination, Unbiased Curriculum, and Advancing Truth in Education (EDUCATE) Act
Vision Center of Excellence funding/support
Provision of vision care within VA health systems
Vision Center of Excellence funding/support
NIH/Defense, vision related research funding
Military Medical Personnel Reductions
Duration: November 1, 2007
to
present
General Issues: Health Issues , Veterans , Defense , Financial Institutions/Investments/Securities , Law Enforcement/Crime/Criminal Justice , Consumer Issues/Safety/Protection , Medicare/Medicaid
Spending: about $14,410,078 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2007: U.S. Senate, House of Representatives, Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS), Veterans Affairs - Dept of (VA), U.S. Senate,, Food & Drug Administration (FDA), Federal Trade Commission (FTC), Centers For Medicare and Medicaid Services (CMS),, Centers For Medicare and Medicaid Services (CMS), Y
Y
Centers for Medicare and Medicaid Services
Department of Health & Human Services
Food & Drug Administration
House of Representatives; United States Senate
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, American Academy of Ophthalmology had in-house lobbyists. The report was filed on April 22.
Original Filing: 301572994.xml
Lobbying Issues
P.L. 111-148 Affordable Care Act, modifications
Prior authorization utilization policies
Medicare Access and CHIP Reauthorization Act (P.L. 114-10) Improvement Issues
Medicare Physician Payment Issues
Drug Pricing and Shortages Issues
Medicare Part B Drug Price Issues
Expansion of Telehealth Services
Vision Research Funding
Implementation of No Surprises Act
The Improving Seniors' Timely Access to Care Act
S. 652/H.R. 2630, the Safe Step Act
The Ensuring Lasting Smiles Act
Medicare Coverage for Low Vision Devices
S. 1573/H.R. 3226 - Preemie Reauthorization Act of 2023
H.R.2474 - Strengthening Medicare for Patients and Providers Act
Healthcare Workforce Issues
H.R. 6545, the Physician Fee Schedule Update and Improvements Act
H.R. 6683, the Preserving Seniors Access to Physicians Act of 2023
H.R. 6487/S. 3805, the No Fees for EFTs Act
H.R. 4968, the GOLD CARD Act
H.R. 830/S. 1375, the Help Ensure Lower Patient Copays Act (HELP Copays Act)
H.R. 2748, the Contact Lens Prescription Verification Modernization Act
H.R. 1503, the Prescription Information Modernization Act of 2023
H.R. 7745, the Embracing Anti-Discrimination, Unbiased Curriculum, and Advancing Truth in Education (EDUCATE) Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Vision Center of Excellence funding/support
Provision of vision care within VA health systems
Agencies Lobbied
U.S. Senate U.S. House of Representatives Veterans Affairs - Dept of (VA)
Lobbying Issues
Vision Center of Excellence funding/support
NIH/Defense, vision related research funding
Military Medical Personnel Reductions
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2023
In Q4, American Academy of Ophthalmology had in-house lobbyists. The report was filed on Jan. 19.
Original Filing: 301531841.xml
Lobbying Issues
P.L. 111-148 Affordable Care Act, modifications
Prior authorization utilization policies
Medicare Access and CHIP Reauthorization Act (P.L. 114-10) Improvement Issues
Medicare Physician Payment Issues
Drug Pricing and Shortages Issues
Medicare Part B Drug Price Issues
Expansion of Telehealth Services
Vision Research Funding
Implementation of No Surprise Act
The Improving Seniors' Timely Access to Care Act
S. 652/H.R. 2630, the Safe Step Act
The Ensuring Lasting Smiles Act
Medicare Coverage for Low Vision Devices
S. 1573/H.R. 3226 - Preemie Reauthorization Act of 2023
H.R.2474 - Strengthening Medicare for Patients and Providers Act
Healthcare Workforce Issues
H.R. 6545, the Physician Fee Schedule Update and Improvements Act
H.R. 6683, the Preserving Seniors Access to Physicians Act of 2023
H.R. 6487, the No Fees for EFTs Act
H.R. 4968, the GOLD CARD Act
H.R. 830/S. 1375, the Help Ensure Lower Patient Copays Act (HELP Copays Act)
H.R. 2748, the Contact Lens Prescription Verification Modernization Act
H.R. 1503, the Prescription Information Modernization Act of 2023
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Vision Center of Excellence funding/support
Provision of vision care within VA health systems
Agencies Lobbied
U.S. Senate U.S. House of Representatives Veterans Affairs - Dept of (VA)
Lobbying Issues
Vision Center of Excellence funding/support
NIH/Defense, vision related research funding
Military Medical Personnel Reductions
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2023
In Q3, American Academy of Ophthalmology had in-house lobbyists. The report was filed on Oct. 19, 2023.
Original Filing: 301507432.xml
Lobbying Issues
P.L. 111-148 Affordable Care Act, modifications
Prior authorization utilization policies
Medicare Access and CHIP Reauthorization Act (P.L. 114-10) Improvement Issues
Medicare Physician Payment Issues
Drug Pricing and Shortages Issues
Medicare Part B Drug Price Issues
Expansion of Telehealth Services
Vision Research Funding
Implementation of No Surprise Act
The Improving Seniors' Timely Access to Care Act
S. 652/H.R. 2630, the Safe Step Act
The Ensuring Lasting Smiles Act
Medicare Coverage for Low Vision Devices
S. 1573/H.R. 3226 - Preemie Reauthorization Act of 2023
H.R.2474 - Strengthening Medicare for Patients and Providers Act
Healthcare Workforce Issues
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Vision Center of Excellence funding/support
Provision of vision care within VA health systems
Agencies Lobbied
U.S. Senate U.S. House of Representatives Veterans Affairs - Dept of (VA)
Lobbying Issues
Vision Center of Excellence funding/support
NIH/Defense, vision related research funding
Military Medical Personnel Reductions
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2023
In Q2, American Academy of Ophthalmology had in-house lobbyists. The report was filed on July 20, 2023.
Original Filing: 301489925.xml
Lobbying Issues
P.L. 111-148 Affordable Care Act, modifications
Prior authorization utilization policies
Medicare Access and CHIP Reauthorization Act (P.L. 114-10) Improvement Issues
Medicare Physician Payment Issues
Drug Pricing and Shortages Issues
Medicare Part B Drug Price Issues
Expansion of Telehealth Services
Vision Research Funding
Implementation of No Surprise Act
The Improving Seniors' Timely Access to Care Act
S. 652/H.R. 2630, the Safe Step Act
The Ensuring Lasting Smiles Act
Medicare Coverage for Low Vision Devices
S. 4333, the CLEAR Act
S. 1573/H.R. 3226 - Preemie Reauthorization Act of 2023
H.R.2474 - Strengthening Medicare for Patients and Providers Act
Healthcare Workforce Issues
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Vision Center of Excellence funding/support
Provision of vision care within VA health systems
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Vision Center of Excellence funding/support
NIH/Defense, vision related research funding
Military Medical Personnel Reductions
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2023
In Q1, American Academy of Ophthalmology had in-house lobbyists. The report was filed on April 19, 2023.
Original Filing: 301456544.xml
Lobbying Issues
P.L. 111-148 Affordable Care Act, modifications
Prior authorization utilization policies
Medicare Access and CHIP Reauthorization Act (P.L. 114-10) Improvement Issues
Medicare Physician Payment Issues
Drug Pricing and Shortages Issues
Medicare Part B Drug Price Issues
Expansion of Telehealth Services
Vision Research Funding
Implementation of No Surprise Act
The Improving Seniors' Timely Access to Care Act
S. 652, Safe Step Act
The Ensuring Lasting Smiles Act
Medicare Coverage for Low Vision Devices
S. 4333, the CLEAR Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Vision Center of Excellence funding/support
Provision of vision care within VA health systems
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Vision Center of Excellence funding/support
NIH/Defense, vision related research funding
Military Medical Personnel Reductions
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2022
In Q4, American Academy of Ophthalmology had in-house lobbyists. The report was filed on Jan. 20, 2023.
Original Filing: 301442139.xml
Lobbying Issues
P.L. 111-148 Affordable Care Act, modifications
Prior authorization utilization policies
Medicare Access and CHIP Reauthorization Act (P.L. 114-10)
Medicare Physician Payment Reform Issues
Medicare sequestration cuts
Drug Pricing and Shortages Issues
Medicare Part B Drug Price Issues
Expansion of Telehealth Services
Vision Research Funding
Implementation of No Surprise Act
HR 3173/S 3018, the Improving Seniors' Timely Access to Care Act
HR 2163/S 464, Safe Step Act
HR 1916/S 754, Ensuring Lasting Smiles Act
Medicare Coverage for Low Vision Devices
HR 4187, the Medicare Vision Act
HR 869/S 289, Research Investment to Spark the Economy (RISE) Act
HR 366, Protecting Access to Post-COVID 19 Telehealth Act
HR3662, Patient Access to Urgent-Use Pharmacy Compounding Act of 2021
HR 3353, the Contact Lens Prescription Verification Modernization Act
HR4122, Resident Education Deferred Interest (REDI) Act
HR 5376, the Build Back Better Act
HR 6000, Cures 2.0 Act
S. 4333, the CLEAR Act
S. 4348, Food and Drug Administration Safety & Landmark Advancements (FDASLA) Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Vision Center of Excellence funding/support
Provision of vision care within VA health systems
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Vision Center of Excellence funding/support
NIH/Defense, vision related research funding
Military Medical Personnel Reductions
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2022
In Q3, American Academy of Ophthalmology had in-house lobbyists. The report was filed on Oct. 20, 2022.
Original Filing: 301416990.xml
Lobbying Issues
P.L. 111-148 Affordable Care Act, modifications
Prior authorization utilization policies
Medicare Access and CHIP Reauthorization Act (P.L. 114-10)
Medicare Physician Payment Reform Issues
Medicare sequestration cuts
Drug Pricing and Shortages Issues
Medicare Part B Drug Price Issues
Expansion of Telehealth Services
Vision Research Funding
Implementation of No Surprise Act
HR 3173/S 3018, the Improving Seniors' Timely Access to Care Act
HR 2163/S 464, Safe Step Act
HR 1916/S 754, Ensuring Lasting Smiles Act
Medicare Coverage for Low Vision Devices
HR 4187, the Medicare Vision Act
HR 869/S 289, Research Investment to Spark the Economy (RISE) Act
HR 366, Protecting Access to Post-COVID 19 Telehealth Act
HR3662, Patient Access to Urgent-Use Pharmacy Compounding Act of 2021
HR 3353, the Contact Lens Prescription Verification Modernization Act
HR4122, Resident Education Deferred Interest (REDI) Act
HR 5376, the Build Back Better Act
HR 6000, Cures 2.0 Act
S. 4333, the CLEAR Act
S. 4348, Food and Drug Administration Safety & Landmark Advancements (FDASLA) Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Vision Center of Excellence funding/support
Provision of vision care within VA health systems
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Vision Center of Excellence funding/support
NIH/Defense, vision related research funding
Military Medical Personnel Reductions
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2022
In Q2, American Academy of Ophthalmology had in-house lobbyists. The report was filed on July 20, 2022.
Original Filing: 301390451.xml
Lobbying Issues
P.L. 111-148 Affordable Care Act, modifications
Prior authorization utilization policies
Medicare Access and CHIP Reauthorization Act (P.L. 114-10) Implementation Issues
Medicare Physician Payment Issues
HR 315, Medicare Sequester COVID Moratorium Act
Drug Pricing and Shortages Issues
Medicare Part B Drug Price Issues
Expansion of Telehealth Services
Vision Research Funding
Implementation of No Surprise Act
HR 3173/S 3018, the Improving Seniors' Timely Access to Care Act
HR 2163/S 464, Safe Step Act
HR 1916/S 754, Ensuring Lasting Smiles Act
Medicare Coverage for Vision Services
Medicare Coverage for Low Vision Devices
HR 4187, the Medicare Vision Act
Coronavirus Pandemic Relief Measures
HR 869/S 289, Research Investment to Spark the Economy (RISE) Act
HR 366, Protecting Access to Post-COVID 19 Telehealth Act
HR3662, Patient Access to Urgent-Use Pharmacy Compounding Act of 2021
HR 3353, the Contact Lens Prescription Verification Modernization Act
HR4122, Resident Education Deferred Interest (REDI) Act
HR 5376, the Build Back Better Act
HR 6000, Cures 2.0 Act
S. 4333, the CLEAR Act
S. 4348, Food and Drug Administration Safety & Landmark Advancements (FDASLA) Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Vision Center of Excellence funding/support
Provision of vision care within VA health systems
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Vision Center of Excellence funding/support
NIH/Defense, vision related research funding
Military Medical Personnel Reductions
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2022
In Q1, American Academy of Ophthalmology had in-house lobbyists. The report was filed on April 19, 2022.
Original Filing: 301362845.xml
Lobbying Issues
P.L. 111-148 Affordable Care Act, modifications
Prior authorization utilization policies
Medicare Access and CHIP Reauthorization Act (P.L. 114-10) Implementation Issues
Medicare Physician Payment Issues
HR 315, Medicare Sequester COVID Moratorium Act
Drug Pricing and Shortages Issues
Medicare Part B Drug Price Issues
Expansion of Telehealth Services
Vision Research Funding
Implementation of No Surprise Act
HR 3173/S 3018, the Improving Seniors' Timely Access to Care Act
HR 2163/S 464, Safe Step Act
HR 1916/S 754, Ensuring Lasting Smiles Act
Medicare Coverage for Vision Services
Medicare Coverage for Low Vision Devices
HR 4187, the Medicare Vision Act
Coronavirus Pandemic Relief Measures
HR 869/S 289, Research Investment to Spark the Economy (RISE) Act
HR 366, Protecting Access to Post-COVID 19 Telehealth Act
HR3662, Patient Access to Urgent-Use Pharmacy Compounding Act of 2021
HR 3353, the Contact Lens Prescription Verification Modernization Act
HR4122, Resident Education Deferred Interest (REDI) Act
HR 5376, the Build Back Better Act
HR 6000, Cures 2.0 Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Lobbying Issues
Vision Center of Excellence funding/support
Provision of vision care within VA health systems
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Vision Center of Excellence funding/support
NIH/Defense, vision related research funding
Military Medical Personnel Reductions
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2021
In Q4, American Academy of Ophthalmology had in-house lobbyists. The report was filed on Jan. 20, 2022.
Original Filing: 301334797.xml
Lobbying Issues
P.L. 111-148 Affordable Care Act, modifications
P.L. 113-54, Drug Quality & Security Act, all sections
Prior authorization utilization policies
Medicare Access and CHIP Reauthorization Act (P.L. 114-10) Implementation Issues
Medicare Physician Payment Issues
HR 315, Medicare Sequester COVID Moratorium Act
Drug Pricing and Shortages Issues
Medicare Part B Drug Price Issues
Proposed MFN Drug Pricing Demo
Expansion of Telehealth Services
Vision Research Funding
Implementation of No Surprise Act
HR 3173/S 3018, the Improving Seniors' Timely Access to Care Act
HR 2163/S 464, Safe Step Act
HR 1916/S 754, Ensuring Lasting Smiles Act
Medicare Coverage for Vision Services
Medicare Coverage for Low Vision Devices
HR 4187, the Medicare Vision Act
Coronavirus Pandemic Relief Measures
HR 1799, the PPP Extension Act
HR 1319, the American Rescue Plan Act of 2021
HR 869/S 289, Research Investment to Spark the Economy (RISE) Act
HR 366, Protecting Access to Post-COVID 19 Telehealth Act
HR3662, Patient Access to Urgent-Use Pharmacy Compounding Act of 2021
HR 3353, the Contact Lens Prescription Verification Modernization Act
HR4122, Resident Education Deferred Interest (REDI) Act
HR 6020, the Supporting Medicare Providers Act of 2021
HR 5376, the Build Back Better Act
HR 6000, Cures 2.0 Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Lobbying Issues
Vision Center of Excellence funding/support
Provision of vision care within VA health systems
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Vision Center of Excellence funding/support
NIH/Defense, vision related research funding
Military Medical Personnel Reductions
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
HR 1799, the PPP Extension Act
HR 1319, the American Rescue Plan Act of 2021
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Financial Institutions/Investments/Securities
3rd Quarter, 2021
In Q3, American Academy of Ophthalmology had in-house lobbyists. The report was filed on Oct. 19, 2021.
Original Filing: 301304448.xml
Lobbying Issues
P.L. 111-148 Affordable Care Act, modifications
P.L. 113-54, Drug Quality & Security Act, all sections
Prior authorization utilization policies
Medicare Access and CHIP Reauthorization Act (P.L. 114-10) Implementation Issues
Medicare Physician Payment Issues
HR 315, Medicare Sequester COVID Moratorium Act
Drug Pricing and Shortages Issues
Medicare Part B Drug Price Issues
Proposed MFN Drug Pricing Demo
Expansion of Telehealth Services
Vision Research Funding
Implementation of No Surprise Act
HR 3173, Improving Seniors' Timely Access to Care Act
HR 2163/S 464, Safe Step Act
HR 1916/S 754, Ensuring Lasting Smiles Act
Medicare Coverage for Vision Services
Medicare Coverage for Low Vision Devices
HR 4187, the Medicare Vision Act
Coronavirus Pandemic Relief Measures
HR 1799, the PPP Extension Act
HR 1319, the American Rescue Plan Act of 2021
HR 869, S. 289, Research Investment to Spark the Economy (RISE) Act
HR 366, Protecting Access to Post-COVID 19 Telehealth Act
HR3662, Patient Access to Urgent-Use Pharmacy Compounding Act of 2021
HR 3353, the Contact Lens Prescription Verification Modernization Act
HR4122, Resident Education Deferred Interest (REDI) Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Lobbying Issues
Vision Center of Excellence funding/support
Provision of vision care within VA health systems
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Vision Center of Excellence funding/support
NIH/Defense, vision related research funding
Military Medical Personnel Reductions
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
HR 1799, the PPP Extension Act
HR 1319, the American Rescue Plan Act of 2021
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Financial Institutions/Investments/Securities
2nd Quarter, 2021
In Q2, American Academy of Ophthalmology had in-house lobbyists. The report was filed on July 14, 2021.
Original Filing: 301276296.xml
Lobbying Issues
P.L. 111-148 Affordable Care Act, modifications
P.L. 113-54, Drug Quality & Security Act, all sections
Prior authorization utilization policies
Medicare Access and CHIP Reauthorization Act (P.L. 114-10) Implementation Issues
Medicare Physician Payment Issues
HR 315, Medicare Sequester COVID Moratorium Act
Drug Pricing and Shortages Issues
Medicare Part B Drug Price Issues
Proposed MFN Drug Pricing Demo
Expansion of Telehealth Services
Vision Research Funding
Implementation of Surprise Medical Bills Legislation
HR 3173, Improving Seniors' Timely Access to Care Act
HR 2163/S 464, Safe Step Act
HR 1916/S 754, Ensuring Lasting Smiles Act
Medicare Coverage for Vision Services
Medicare Coverage for Low Vision Devices
HR 4187, the Medicare Vision Act
Coronavirus Pandemic Relief Measures
HR 1799, the PPP Extension Act
HR 1319, the American Rescue Plan Act of 2021
HR 869, S. 289, Research Investment to Spark the Economy (RISE) Act
HR 366, Protecting Access to Post-COVID 19 Telehealth Act
HR3662, Patient Access to Urgent-Use Pharmacy Compounding Act of 2021
HR 3353, the Contact Lens Prescription Verification Modernization Act
HR4122, Resident Education Deferred Interest (REDI) Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Lobbying Issues
Vision Center of Excellence funding/support
Provision of vision care within VA health systems
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Vision Center of Excellence funding/support
NIH/Defense, vision related research funding
Military Medical Personnel Reductions
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
HR 133, Consolidated Appropriations Act, 2021 (Omnibus Appropriations/COVID-19 Relief bill)
HR 1799, the PPP Extension Act
HR 1319, the American Rescue Plan Act of 2021
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Financial Institutions/Investments/Securities
1st Quarter, 2021
In Q1, American Academy of Ophthalmology had in-house lobbyists. The report was filed on April 15, 2021.
Original Filing: 301253362.xml
Lobbying Issues
P.L. 111-148 Affordable Care Act, modifications
P.L. 113-54, Drug Quality & Security Act, all sections
Prior authorization utilization policies
Medicare Access and CHIP Reauthorization Act (P.L. 114-10) Implementation Issues
Medicare Physician Payment Issues
HR315, Medicare Sequester COVID Moratorium Act
Drug Pricing and Shortages Issues
Medicare Part B Drug Price Issues
Proposed MFN Drug Pricing Demo
Expansion of Telehealth Services
Vision Research Funding
Implementation of Surprise Medical Bills Legislation
HR 3107, Improving Seniors' Timely Access to Care Act
HR 2163/S 464, Safe Step Act
HR 1916/S 754, Ensuring Lasting Smiles Act
Medicare Coverage for Vision Services
Medicare Coverage for Low Vision Devices
Coronavirus Pandemic Relief Measures
HR 1799, the PPP Extension Act
HR 1319, the American Rescue Plan Act of 2021
HR 869, S. 289, Research Investment to Spark the Economy (RISE) Act
HR 366, Protecting Access to Post-COVID 19 Telehealth Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Lobbying Issues
Vision Center of Excellence funding/support
Provision of vision care within VA health systems
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Vision Center of Excellence funding/support
NIH/Defense, vision related research funding
Military Medical Personnel Reductions
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
HR 133, Consolidated Appropriations Act, 2021 (Omnibus Appropriations/COVID-19 Relief bill)
HR 1799, the PPP Extension Act
HR 1319, the American Rescue Plan Act of 2021
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Financial Institutions/Investments/Securities
4th Quarter, 2020
In Q4, American Academy of Ophthalmology had in-house lobbyists. The report was filed on Jan. 21, 2021.
Original Filing: 301245053.xml
Lobbying Issues
HR 6663, Truth in Health Care Marketing Act
P.L. 111-148 Affordable Care Act, modifications:
1. Reducing regulatory/costly burdens on medical practices - relief from regulatory burdens
2. Preserving patient access to office ancillary testing services
Meaningful Use/EHR program issues
P.L. 113-54, Drug Quality & Security Act, all sections
Medicare Advantage plan network adequacy
Prior authorization utilization policies
Medicare Part B Drug Price Issues
Medicare Access and CHIP Reauthorization Act (P.L. 114-10) Implementation Issues
Proposed Contact Lens Rule Modifications
Medicare Physician Payment Issues
Drug Pricing and Shortages Issues
S. 2020, SEE MORE ACT
Vision Research Funding
Medical Surprise Billing Legislative proposals
HR 3107, Improving Seniors' Timely Access to Care Act
HR 3975, Contact Lens Prescription Verification Modernization Act
S. 4613, Contact Lens Rule Modernization Act
HR 2279/S.2546, Safe Step Act
HR 4665, The Medicare Vision Act
HR 3, Elijah Cummings Lower Drug Cost Now Act
Coronavirus Pandemic Relief Measures
HR 6365/S.3559 Immediate Relief for Rural Facilities and Providers Act
HR 7059, Coronavirus Provider Protection Act
HR 2620, Faster Treatments and Cures for Eye Diseases Act
HR 7819, Eliminating the Provider Relief Fund Tax Penalties Act
S. 4295, Public Health Emergency Pass-Through Payment Fairness Act
HR 8624, Protecting Access to Innovation During COVID-19 Act
S.4932, the Medicare Reimbursement Equity Act
HR 8702/S. 5007, the Holding Providers Harmless From Medicare Cuts During COVID-19 Act
HR 8505, a bill to waive budget neutrality requirements of the Medicare Physician Fee Schedule
H.R. 8709, the Analyzing Kinetic Impact Projectiles (KIPs) Against Americans Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Lobbying Issues
Vision Center of Excellence funding/support
Provision of vision care within VA health systems
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Vision Center of Excellence funding/support
NIH/Defense, vision related research funding
Military Medical Personnel Reductions
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Legislative issues related to policing tactics
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Law Enforcement/Crime/Criminal Justice
Lobbying Issues
HR 6800, Health and Economic Recovery Omnibus Emergency Solutions Act or the HEROES Act, 2020
HR 6782, Paycheck Protection Program Flexibility Act, 2020
The Health, Economic Assistance, Liability Protection, and Schools Act
HR 133, Consolidated Appropriations Act, 2021 (Omnibus Appropriations/COVID-19 Relief bill)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Financial Institutions/Investments/Securities
3rd Quarter, 2020
In Q3, American Academy of Ophthalmology had in-house lobbyists. The report was filed on Oct. 19, 2020.
Original Filing: 301215191.xml
Lobbying Issues
HR 6663, Truth in Health Care Marketing Act
P.L. 111-148 Affordable Care Act, modifications:
1. Reducing regulatory/costly burdens on medical practices - relief from regulatory burdens
2. Preserving patient access to office ancillary testing services
Meaningful Use/EHR program issues
P.L. 113-54, Drug Quality & Security Act, all sections
Medicare Advantage plan network adequacy
Prior authorization utilization policies
Medicare Part B Drug Price Issues
Medicare Access and CHIP Reauthorization Act (P.L. 114-10) Implementation Issues
Proposed Contact Lens Rule Modifications
Medicare Physician Payment Issues
Drug Pricing and Shortages Issues
S. 2020, SEE MORE ACT
Vision Research Funding
Medical Surprise Billing Legislative proposals
HR 3107, Improving Seniors' Timely Access to Care Act
HR 3975, Contact Lens Prescription Verification Modernization Act
HR 2279/S.2546, Safe Step Act
HR 4665, The Medicare Vision Act
HR 3, Elijah Cummings Lower Drug Cost Now Act
Coronavirus Pandemic Relief Measures
HR 6365/S.3559 Immediate Relief for Rural Facilities and Providers Act
HR 7059, Coronavirus Provider Protection Act
HR 2620, Faster Treatments and Cures for Eye Diseases Act
HR 7819, Eliminating the Provider Relief Fund Tax Penalties Act
S. 4295, Public Health Emergency Pass-Through Payment Fairness Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Lobbying Issues
Vision Center of Excellence funding/support
Provision of vision care within VA health systems
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Vision Center of Excellence funding/support
NIH/Defense, vision related research funding
Military Medical Personnel Reductions
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Legislative issues related to policing tactics
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Law Enforcement/Crime/Criminal Justice
Lobbying Issues
HR 6800, Health and Economic Recovery Omnibus Emergency Solutions Act or the HEROES Act, 2020
HR 6782, Paycheck Protection Program Flexibility Act, 2020
The Health, Economic Assistance, Liability Protection, and Schools Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Financial Institutions/Investments/Securities
2nd Quarter, 2020
In Q2, American Academy of Ophthalmology had in-house lobbyists. The report was filed on July 17, 2020.
Original Filing: 301191469.xml
Lobbying Issues
H.R. 6663, Truth in Health Care Marketing Act
P.L. 111-148 Affordable Care Act, modifications:
1. Reducing regulatory/costly burdens on medical practices - relief from regulatory burdens
2. Preserving patient access to office ancillary testing services
Meaningful Use/EHR program issues
P.L. 113-54, Drug Quality & Security Act, all sections
Medicare Advantage plan network adequacy
Prior authorization utilization policies
Medicare Part B Drug Price Issues
Medicare Access and CHIP Reauthorization Act (P.L. 114-10) Implementation Issues
Proposed Contact Lens Rule Modifications
Medicare Physician Payment Issues
Drug Pricing and Shortages Issues
CREATES ACT, S.340
SEE MORE ACT, S.2020
Vision Research Funding
Medical Surprise Billing Legislative proposals
HR3107, Improving Seniors' Timely Access to Care Act
HR3975, Contact Lens Prescription Verification Modernization Act
HR2279/S.2546, Safe Step Act
HR4665, The Medicare Vision Act
HR3, Elijah Cummings Lower Drug Cost Now Act
S.2723 Mitigating Emergency Drug Shortage Act (MEDS)
Coronavirus Pandemic Relief Measures
HR6365/S.3559 Immediate Relief for Rural Facilities and Providers Act
HR7059, Coronavirus Provider Protection Act
HR2620, Faster Treatments and Cures for Eye Diseases Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Lobbying Issues
Vision Center of Excellence funding/support
Provision of vision care within VA health systems
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Vision Center of Excellence funding/support
NIH/Defense, vision related research funding
Military Medical Personnel Reductions
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Legislative issues related to policing tactics
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Law Enforcement/Crime/Criminal Justice
1st Quarter, 2020
In Q1, American Academy of Ophthalmology had in-house lobbyists. The report was filed on April 16, 2020.
Original Filing: 301168096.xml
Lobbying Issues
Truth in Health Care Marketing Act
P.L. 111-148 Affordable Care Act, modifications:
1. Reducing regulatory/costly burdens on medical practices - relief from regulatory burdens
2. Preserving patient access to office ancillary testing services
Meaningful Use/EHR program issues
P.L. 113-54, Drug Quality & Security Act, all sections
Medicare Advantage plan network adequacy
Prior authorization utilization policies
Medicare Part B Drug Price Issues
Medicare Access and CHIP Reauthorization Act (P.L. 114-10) Implementation Issues
Proposed Contact Lens Rule Modifications
Medicare Physician Payment Issues
Drug Pricing and Shortages Issues
CREATES ACT, S.340
SEE MORE ACT, S.2020
Vision Research Funding
Medical Surprise Billing Legislative proposals
HR3107, Improving Seniors' Timely Access to Care Act
HR3975, Contact Lens Prescription Verification Modernization Act
HR2279/S.2546, Safe Step Act
HR4665, The Medicare Vision Act
HR3, Elijah Cummings Lower Drug Cost Now Act
S.2723 Mitigating Emergency Drug Shortage Act (MEDS)
Coronavirus Pandemic Relief Measures
HR6365/S.3559 Immediate Relief for Rural Facilities and Providers Act
HR3975 Contact Lens Prescription Verification Modernization Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Lobbying Issues
Vision Center of Excellence funding/support
Provision of vision care within VA health systems
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Vision Center of Excellence funding/support
NIH/Defense, vision related research funding
Military Medical Personnel Reductions
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2019
In Q4, American Academy of Ophthalmology had in-house lobbyists. The report was filed on Jan. 17, 2020.
Original Filing: 301108661.xml
Lobbying Issues
Truth in Health Care Marketing Act
P.L. 111-148 Affordable Care Act, modifications:
1. Reducing regulatory/costly burdens on medical practices - relief from regulatory burdens
2. Preserving patient access to office ancillary testing services
Meaningful Use/EHR program issues
P.L. 113-54, Drug Quality & Security Act, all sections
Medicare Advantage plan network adequacy
Prior authorization utilization policies
Medicare Part B Drug Price Issues
Medicare Access and CHIP Reauthorization Act (P.L. 114-10) Implementation Issues
Proposed Contact Lens Rule Modifications
Medicare Physician Payment Issues
Drug Pricing and Shortages Issues
CREATES ACT, S.340
SEE MORE ACT, S.2020
Vision Research Funding
Medical Surprise Billing Legislative proposals
HR3107, Improving Seniors' Timely Access to Care Act
HR3975, Contact Lens Prescription Verification Modernization Act
HR2279/S.2546, Safe Step Act
HR4665, The Medicare Vision Act
HR3, Elijah Cummings Lower Drug Cost Now Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Lobbying Issues
Vision Center of Excellence funding/support
Provision of vision care within VA health systems
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Vision Center of Excellence funding/support
NIH/Defense, vision related research funding
Military Medical Personnel Reductions
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2019
In Q3, American Academy of Ophthalmology had in-house lobbyists. The report was filed on Oct. 9, 2019.
Original Filing: 301064190.xml
Lobbying Issues
Access to Frontline Health Care Act, all sections
Truth in Health Care Marketing Act
P.L. 111-148 Affordable Care Act, modifications:
1. Reducing regulatory/costly burdens on medical practices - relief from regulatory burdens
2. Preserving patient access to office ancillary testing services
Meaningful Use/EHR program issues
P.L. 113-54, Drug Quality & Security Act, all sections
Medicare Advantage plan network adequacy
Prior authorization utilization policies
Medicare Part B Drug Price Issues
Medicare Access and CHIP Reauthorization Act (P.L. 114-10) Implementation Issues
Proposed Contact Lens Rule Modifications
Medicare Physician Payment Issues
Drug Pricing and Shortages Issues
CREATES ACT, S.340
SEE MORE ACT, S.2020
Vision Research Funding
Medical Surprise Billing Legislative proposals
HR3107, Improving Seniors' Timely Access to Care Act
Surprise Medical Billing Legislation
HR3975, Contact Lens Prescription Verification Modernization Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Lobbying Issues
Vision Center of Excellence funding/support
Provision of vision care within VA health systems
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Vision Center of Excellence funding/support
NIH/Defense, vision related research funding
Military Medical Personnel Reductions
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2019
In Q2, American Academy of Ophthalmology had in-house lobbyists. The report was filed on July 22, 2019.
Original Filing: 301056320.xml
Lobbying Issues
Access to Frontline Health Care Act, all sections
Truth in Health Care Marketing Act
P.L. 111-148 Affordable Care Act, modifications:
1. Reducing regulatory/costly burdens on medical practices - relief from regulatory burdens
2. Preserving patient access to office ancillary testing services
Meaningful Use/EHR program issues
P.L. 113-54, Drug Quality & Security Act, all sections
Medicare Advantage plan network adequacy
Prior authorization utilization policies
Medicare Part B Drug Price Issues
Medicare Access and CHIP Reauthorization Act (P.L. 114-10) Implementation Issues
Proposed Contact Lens Rule Modifications
Medicare Physician Payment Issues
Drug Pricing and Shortages Issues
CREATES ACT, S.340
SEE MORE ACT, S.2020
Vision Research Funding
Medical Surprise Billing Legislative proposals
HR3107, Improving Seniors' Access to Care Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Lobbying Issues
Vision Center of Excellence funding/support
Provision of vision care within VA health systems
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Vision Center of Excellence funding/support
NIH/Defense, vision related research funding
Military Medical Personnel Reductions
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2019
In Q1, American Academy of Ophthalmology had in-house lobbyists. The report was filed on April 16, 2019.
Original Filing: 301025802.xml
Lobbying Issues
Access to Frontline Health Care Act, all sections
Truth in Health Care Marketing Act
P.L. 111-148 Affordable Care Act, modifications:
1. Reducing regulatory/costly burdens on medical practices - relief from regulatory burdens
2. Preserving patient access to office ancillary testing services
Meaningful Use/EHR program issues
P.L. 113-54, Drug Quality & Security Act, all sections
Medicare Advantage plan network adequacy
Prior authorization utilization policies
Medicare Part B Drug Price Issues
Medicare Access and CHIP Reauthorization Act (P.L. 114-10) Implementation Issues
Proposed Contact Lens Rule Modifications
Medicare Physician Payment Issues
Drug Pricing and Shortages Issues
CREATES ACT, S.340
SEE MORE ACT
Vision Research Funding
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Lobbying Issues
Vision Center of Excellence funding/support
Provision of vision care within VA health systems
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Vision Center of Excellence funding/support
NIH/Defense, vision related research funding
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2018
In Q4, American Academy of Ophthalmology had in-house lobbyists. The report was filed on Jan. 22, 2019.
Original Filing: 301013014.xml
Lobbying Issues
Access to Frontline Health Care Act, all sections
Truth in Health Care Marketing Act
P.L. 111-148 Affordable Care Act, modifications:
1. Reducing regulatory/costly burdens on medical practices - relief from regulatory burdens
2. Preserving patient access to office ancillary testing services
Meaningful Use/EHR program issues
P.L. 113-54, Drug Quality & Security Act, all sections
Medicare Advantage plan network adequacy
Drug Price/prior authorization utilization policies
Medicare Part B Drug Price Issues
Medicare Access and CHIP Reauthorization Act (P.L. 114-10) Implementation Issues
Ensuring Equal Access to Treatment Act
Proposed Contact Lens Rule Modifications
Medicare Physician Payment issues
Drug Shortages Issues
HR 6639, Diabetic Vision Loss and Blindness Prevention Act
S. 3751, the SEE MORE Act
HR 6421, the Faster Treatments and Cures for Eye Diseases Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Lobbying Issues
Vision Center of Excellence funding/support
Caregivers and Veterans Health Services Act, Sec 601 (PL 111-163)
Provision of vision care within VA health systems
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Vision Center of Excellence funding/support
NIH/Defense, vision related research funding
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2018
In Q3, American Academy of Ophthalmology had in-house lobbyists. The report was filed on Oct. 12, 2018.
Original Filing: 300984928.xml
Lobbying Issues
Access to Frontline Health Care Act, all sections
Truth in Health Care Marketing Act
P.L. 111-148 Affordable Care Act, modifications:
1. Reducing regulatory/costly burdens on medical practices - relief from regulatory burdens
2. Preserving patient access to office ancillary testing services
Meaningful Use/EHR program issues
P.L. 113-54, Drug Quality & Security Act, all sections
Medicare Advantage plan network adequacy
Drug Price/prior authorization utilization policies
Medicare Part B Drug Price Issues
Medicare Access and CHIP Reauthorization Act (P.L. 114-10) Implementation Issues
Ensuring Equal Access to Treatment Act
IHS Teleretinal Program Funding
Proposed Contact Lens Rule Modifications
Medicare Physician Payment issues
Drug Shortages Issues
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Lobbying Issues
Vision Center of Excellence funding/support
Caregivers and Veterans Health Services Act, Sec 601 (PL 111-163)
Provision of vision care within VA health systems
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Vision Center of Excellence funding/support
NIH/Defense, vision related research funding
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2018
In Q2, American Academy of Ophthalmology had in-house lobbyists. The report was filed on July 19, 2018.
Original Filing: 300970358.xml
Lobbying Issues
Access to Frontline Health Care Act, all sections
Truth in Health Care Marketing Act
P.L. 111-148 Affordable Care Act, modifications:
1. Reducing regulatory/costly burdens on medical practices - relief from regulatory burdens
2. Preserving patient access to office ancillary testing services
4. Independent Payment Advisory Board
Meaningful Use/EHR program issues
P.L. 113-54, Drug Quality & Security Act, all sections
Medicare Advantage plan network adequacy
Drug Price Increases
Medicare Part B Drug Price Issues
Medicare Access and CHIP Reauthorization Act (P.L. 114-10) Implementation Issues
Ensuring Equal Access to Treatment Act
IHS Teleretinal Program Funding
Proposed Contact Lens Rule Modifications
Medicare Physician Payment issues
Drug Shortages Issues
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Lobbying Issues
Vision Center of Excellence funding/support
Caregivers and Veterans Health Services Act, Sec 601 (PL 111-163)
Provision of vision care within VA health systems
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Vision Center of Excellence funding/support
NIH/Defense, vision related research funding
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2018
In Q1, American Academy of Ophthalmology had in-house lobbyists. The report was filed on April 13, 2018.
Original Filing: 300944594.xml
Lobbying Issues
Access to Frontline Health Care Act, all sections
Truth in Health Care Marketing Act
P.L. 111-148 Affordable Care Act, modifications:
1. Reducing regulatory/costly burdens on medical practices - relief from regulatory burdens
2. Preserving patient access to office ancillary testing services
4. Independent Payment Advisory Board
Meaningful Use/EHR program issues
P.L. 113-54, Drug Quality & Security Act, all sections
Medicare Advantage plan network adequacy
Drug Price Increases
Medicare Part B Drug Price Issues
Medicare Access and CHIP Reauthorization Act (P.L. 114-10) Implementation Issues
Ensuring Equal Access to Treatment Act
IHS Teleretinal Program Funding
Proposed Contact Lens Rule Modifications
Medicare Physician Payment issues
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Lobbying Issues
Vision Center of Excellence funding/support
Caregivers and Veterans Health Services Act, Sec 601 (PL 111-163)
Provision of vision care within VA health systems
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Vision Center of Excellence funding/support
NIH/Defense, vision related research funding
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2017
In Q4, American Academy of Ophthalmology had in-house lobbyists. The report was filed on Jan. 19, 2018.
Original Filing: 300930884.xml
Lobbying Issues
Access to Frontline Health Care Act, all sections
Truth in Health Care Marketing Act
P.L. 111-148 Affordable Care Act, modifications:
1. Reducing regulatory/costly burdens on medical practices - relief from regulatory penalties
2. Preserving patient access to office ancillary testing services
4. Independent Payment Advisory Board
Meaningful Use/EHR program issues
P.L. 113-54, Drug Quality & Security Act, all sections
Medicare Advantage plan network adequacy
Drug Price Increases
Medicare Part B Drug Price Issues
Medicare Access and CHIP Reauthorization Act (P.L. 114-10) Implementation Issues
Ensuring Equal Access to Treatment Act
IHS Teleretinal Program Funding
Proposed Contact Lens Rule Modifications
Medicare Physician Payment issues
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Lobbying Issues
Vision Center of Excellence funding/support
Caregivers and Veterans Health Services Act, Sec 601 (PL 111-163)
Provision of vision care within VA health systems
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Vision Center of Excellence funding/support
NIH/Defense, vision related research funding
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2017
In Q3, American Academy of Ophthalmology had in-house lobbyists. The report was filed on Oct. 20, 2017.
Original Filing: 300915222.xml
Lobbying Issues
Access to Frontline Health Care Act, all sections
Truth in Health Care Marketing Act
P.L. 111-148 Affordable Care Act, modifications:
1. Reducing regulatory/costly burdens on medical practices - relief from regulatory penalties
2. Preserving patient access to office ancillary testing services
4. Independent Payment Advisory Board
Meaningful Use/EHR program issues
P.L. 113-54, Drug Quality & Security Act, all sections
Medicare Advantage plan network adequacy
Drug Price Increases
Medicare Part B Drug Price Issues
Medicare Access and CHIP Reauthorization Act (P.L. 114-10) Implementation Issues
Ensuring Equal Access to Treatment Act
IHS Teleretinal Program Funding
Proposed Contact Lens Rule Modifications
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Lobbying Issues
Vision Center of Excellence funding/support
Caregivers and Veterans Health Services Act, Sec 601 (PL 111-163)
Provision of vision care within VA health systems
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Vision Center of Excellence funding/support
NIH/Defense, vision related research funding
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2017
In Q2, American Academy of Ophthalmology had in-house lobbyists. The report was filed on July 19, 2017.
Original Filing: 300890674.xml
Lobbying Issues
Access to Frontline Health Care Act, all sections
Truth in Health Care Marketing Act
P.L. 111-148 Affordable Care Act, modifications:
1. Reducing regulatory/costly burdens on medical practices - relief from regulatory penalties
2. Preserving patient access to office ancillary testing services
4. Independent Payment Advisory Board
Meaningful Use/EHR program issues
P.L. 113-54, Drug Quality & Security Act, all sections
Medicare Advantage plan network adequacy
Drug Price Increases
Medicare Part B Drug Price Issues
Medicare Access and CHIP Reauthorization Act (P.L. 114-10) Implementation Issues
Ensuring Equal Access to Treatment Act
IHS Teleretinal Program Funding
Proposed Contact Lens Rule Modifications
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Lobbying Issues
Vision Center of Excellence funding/support
Caregivers and Veterans Health Services Act, Sec 601 (PL 111-163)
Provision of vision care within VA health systems
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Vision Center of Excellence funding/support
NIH/Defense, vision related research funding
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2017
In Q1, American Academy of Ophthalmology had in-house lobbyists. The report was filed on April 18, 2017.
Original Filing: 300868307.xml
Lobbying Issues
Access to Frontline Health Care Act, all sections
Truth in Health Care Marketing Act
P.L. 111-148 Affordable Care Act, modifications:
1. Reducing regulatory/costly burdens on medical practices - relief from regulatory penalties
2. Preserving patient access to office ancillary testing services
4. Independent Payment Advisory Board
Meaningful Use/EHR program issues
P.L. 113-54, Drug Quality & Security Act, all sections
Protecting Access to Medicare Act (P.L. 113-93)
Medicare Advantage plan network adequacy
Drug Price Increases
Medicare Part B Drug Price Issues
Medicare Access and CHIP Reauthorization Act (P.L. 114-10) Implementation Issues
Ensuring Equal Access to Treatment Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Lobbying Issues
Vision Center of Excellence funding/support
Caregivers and Veterans Health Services Act, Sec 601 (PL 111-163)
Provision of vision care within VA health systems
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Vision Center of Excellence funding/support
NIH/Defense, vision related research funding
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2016
In Q4, American Academy of Ophthalmology had in-house lobbyists. The report was filed on Jan. 19, 2017.
Original Filing: 300850846.xml
Lobbying Issues
H.R. 1707, Access to Frontline Health Care Act, all sections
H.R. 1741, Truth in Health Marketing Act, all sections
H.R. 1190, Protecting Seniors Access to Medicare Act, all sections
S. 141, Protecting Seniors Access to Medicare Act, all sections
P.L. 111-192, Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act of 2010, all sections related to physicians and vision
P.L. 111-148 Affordable Care Act, modifications:
1. Reducing regulatory/costly burdens on medical practices - relief from regulatory penalties
2. Preserving patient access to office ancillary testing services
4. Independent Payment Advisory Board
H.R. 1312, National Health Service Corps Improvement Act
Meaningful Use/EHR program issues
P.L. 113-54, Drug Quality & Security Act, all sections
Protecting Access to Medicare Act (P.L. 113-93)
ASC Quality Reporting Program
Medicare Advantage plan network adequacy
H.R. 270, FlexIT Act, all sections
H.R. 3309, Flex IT 2 Act, all sections
S. 2141, Trust IT Act
2016 Physician Schedule Rule, sections pertaining to fee cuts
Drug Price Increases
Medicare Part B Drug Demonstration
Medicare Access and CHIP Reauthorization Act (PL114-10)
S.2777, Contact Lens Consumer Health Protection Act
H.R. 6, 21st Century Cures
Proposed 2017 Physician Fee Schedule. Section pertaining to global surgery data collection proposal
H.R. 1178, Ensuring Equal Access to Treatment Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Lobbying Issues
Vision Center of Excellence funding/support
Caregivers and Veterans Health Services Act, Sec 601 (PL 111-163)
Provision of Vision Care within VA health systems
H.R. 1688, Legislation to grant VA residency slots to optometry
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Vision Center of Excellence funding/support
NIH/Defense, vision related research funding
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2016
In Q3, American Academy of Ophthalmology had in-house lobbyists. The report was filed on Oct. 12, 2016.
Original Filing: 300826781.xml
Lobbying Issues
H.R. 1707, Access to Frontline Health Care Act, all sections
H.R. 1741, Truth in Health Marketing Act, all sections
H.R. 1190, Protecting Seniors Access to Medicare Act, all sections
S. 141, Protecting Seniors Access to Medicare Act, all sections
P.L. 111-192, Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act of 2010, all sections related to physicians and vision
P.L. 111-148 Affordable Care Act, modifications:
1. Reducing regulatory/costly burdens on medical practices - relief from regulatory penalties
2. Preserving patient access to office ancillary testing services
4. Independent Payment Advisory Board
H.R. 1312, National Health Service Corps Improvement Act
Meaningful Use/EHR program issues
P.L. 113-54, Drug Quality & Security Act, all sections
Protecting Access to Medicare Act (P.L. 113-93)
ASC Quality Reporting Program
Medicare Advantage plan network adequacy
H.R. 270, FlexIT Act, all sections
H.R. 3309, Flex IT 2 Act, all sections
S. 2141, Trust IT Act
2016 Physician Schedule Rule, sections pertaining to fee cuts
Drug Price Increases
Medicare Part B Drug Demonstration
Medicare Access and CHIP Reauthorization Act (PL114-10)
S.2777, Contact Lens Consumer Health Protection Act
H.R. 6, 21st Century Cures
Proposed 2017 Physician Fee Schedule. Section pertaining to global surgery data collection proposal
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Lobbying Issues
Vision Center of Excellence funding/support
Caregivers and Veterans Health Services Act, Sec 601 (PL 111-163)
Provision of Vision Care within VA health systems
H.R. 1688, Legislation to grant VA residency slots to optometry
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Vision Center of Excellence funding/support
NIH/Defense, vision related research funding
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2016
In Q2, American Academy of Ophthalmology had in-house lobbyists. The report was filed on July 19, 2016.
Original Filing: 300812902.xml
Lobbying Issues
H.R. 1707, Access to Frontline Health Care Act, all sections
H.R. 1741, Truth in Health Marketing Act, all sections
H.R. 1190, Protecting Seniors Access to Medicare Act, all sections
S. 141, Protecting Seniors Access to Medicare Act, all sections
P.L. 111-192, Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act of 2010, all sections related to physicians and vision
P.L. 111-148 Affordable Care Act, modifications:
1. Reducing regulatory/costly burdens on medical practices - relief from regulatory penalties
2. Preserving patient access to office ancillary testing services
3. Essential Benefits - Children's Vision
4. Independent Payment Advisory Board
H.R. 1312, National Health Service Corps Improvement Act
Meaningful Use/EHR program issues
P.L. 113-54, Drug Quality & Security Act, all sections
Protecting Access to Medicare Act (P.L. 113-93)
ASC Quality Reporting Program
Medicare Advantage plan network adequacy
H.R. 270, FlexIT Act, all sections
H.R. 3309, Flex IT 2 Act, all sections
H.R. 3940, Meaningful Use Hardship Relief Act
S. 2141, Trust IT Act
2016 Physician Schedule Rule, sections pertaining to fee cuts
Drug Price Increases
Medicare Part B Drug Demonstration
Medicare Access and CHIP Reauthorization Act (PL114-10)
S.2777, Contact Lens Consumer Health Protection Act
H.R. 6, 21st Century Cures
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Lobbying Issues
Vision Center of Excellence funding/support
Caregivers and Veterans Health Services Act, Sec 601 (PL 111-163)
Provision of Vision Care within VA health systems
H.R. 1688, Legislation to grant VA residency slots to optometry
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Vision Center of Excellence funding/support
NIH/Defense, vision related research funding
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2016
In Q1, American Academy of Ophthalmology had in-house lobbyists. The report was filed on April 19, 2016.
Original Filing: 300795308.xml
Lobbying Issues
Optometric Equity in Medicaid Act, Federal mandates for Medicaid of optometric medical & surgical coverage, all sections
SGR - Medicare Physician Payment Reform
H.R. 1707, Access to Frontline Health Care Act, all sections
H.R. 1741, Truth in Health Marketing Act, all sections
H.R. 1190, Protecting Seniors Access to Medicare Act, all sections
S. 141, Protecting Seniors Access to Medicare Act, all sections
P.L. 111-192, Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act of 2010, all sections related to physicians and vision
P.L. 111-148 Affordable Care Act, modifications:
1. Reducing regulatory/costly burdens on medical practices - relief from regulatory penalties
2. Preserving patient access to office ancillary testing services
3. Essential Benefits - Children's Vision
4. Independent Payment Advisory Board
H.R. 1312, National Health Service Corps Improvement Act
Meaningful Use/EHR program issues
P.L. 113-54, Drug Quality & Security Act, all sections
Protecting Access to Medicare Act (P.L. 113-93)
ASC Quality Reporting Program
Medicare Advantage plan network adequacy
H.R. 270, FlexIT Act, all sections
H.R. 3309, Flex IT 2 Act, all sections
H.R. 3940, Meaningful Use Hardship Relief Act
S. 2141, Trust IT Act
2016 Physician Schedule Rule, sections pertaining to fee cuts
Drug Price Increases
Medicare Part B Drug Demonstration
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Lobbying Issues
Vision Center of Excellence funding/support
Caregivers and Veterans Health Services Act, Sec 601 (PL 111-163)
Provision of Vision Care within VA health systems
H.R. 1688, Legislation to grant VA residency slots to optometry
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Vision Center of Excellence funding/support
NIH/Defense, vision related research funding
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2015
In Q4, American Academy of Ophthalmology had in-house lobbyists. The report was filed on Jan. 20, 2016.
Original Filing: 300782938.xml
Lobbying Issues
Optometric Equity in Medicaid Act, Federal mandates for Medicaid of optometric medical & surgical coverage, all sections
SGR - Medicare Physician Payment Reform
H.R. 1707, Access to Frontline Health Care Act, all sections
H.R. 1741, Truth in Health Marketing Act, all sections
H.R. 1190, Protecting Seniors Access to Medicare Act, all sections
S. 141, Protecting Seniors Access to Medicare Act, all sections
P.L. 111-192, Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act of 2010, all sections related to physicians and vision
P.L. 111-148 Affordable Care Act, modifications:
1. Reducing regulatory/costly burdens on medical practices - relief from regulatory penalties
2. Preserving patient access to office ancillary testing services
3. Essential Benefits - Children's Vision
4. Independent Payment Advisory Board
H.R. 1312, National Health Service Corps Improvement Act
Meaningful Use/EHR program issues
P.L. 113-54, Drug Quality & Security Act, all sections
H.R. 2, Medicare Access & CHIP Reauthorization Act
Protecting Access to Medicare Act (P.L. 113-93)
ASC Quality Reporting Program
Medicare Advantage plan network adequacy
2015 Physician Schedule Rule, Issues pertaining to clinical data regional/global surgery payments
H.R. 270, FlexIT Act, all sections
H.R. 3309, Flex IT 2 Act, all sections
H.R. 3940, Meaningful Use Hardship Relief Act
S. 2141, Trust IT Act
2016 Physician Schedule Rule, sections pertaining to fee cuts
Drug Price Increases
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Lobbying Issues
Vision Center of Excellence funding/support
Caregivers and Veterans Health Services Act, Sec 601 (PL 111-163)
Provision of Vision Care within VA health systems
H.R. 1688, Legislation to grant VA residency slots to optometry
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Vision Center of Excellence funding/support
NIH/Defense, vision related research funding
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2015
In Q3, American Academy of Ophthalmology had in-house lobbyists. The report was filed on Oct. 20, 2015.
Original Filing: 300764108.xml
Lobbying Issues
Optometric Equity in Medicaid Act, Federal mandates for Medicaid of optometric medical & surgical coverage, all sections
SGR - Medicare Physician Payment Reform
H.R. 1707, Access to Frontline Health Care Act, all sections
H.R. 1741, Truth in Health Marketing Act, all sections
H.R. 1190, Protecting Seniors Access to Medicare Act, all sections
S. 141, Protecting Seniors Access to Medicare Act, all sections
P.L. 111-192, Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act of 2010, all sections related to physicians and vision
P.L. 111-148 Affordable Care Act, modifications:
1. Reducing regulatory/costly burdens on medical practices - relief from regulatory penalties
2. Preserving patient access to office ancillary testing services
3. Essential Benefits - Children's Vision
4. Independent Payment Advisory Board
H.R. 1312, National Health Service Corps Improvement Act
Meaningful Use/EHR program issues
P.L. 113-54, Drug Quality & Security Act, all sections
H.R. 2, Medicare Access & CHIP Reauthorization Act
Protecting Access to Medicare Act (P.L. 113-93)
ASC Quality Reporting Program
Medicare Advantage plan network adequacy
2015 Physician Schedule Rule, Issues pertaining to clinical data regional/global surgery payments
H.R. 270, FlexIT Act
H.R. 3309, Flex IT 2 Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Lobbying Issues
Vision Center of Excellence funding/support
Caregivers and Veterans Health Services Act, Sec 601 (PL 111-163)
Provision of Vision Care within VA health systems
H.R. 1688, Legislation to grant VA residency slots to optometry
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Vision Center of Excellence funding/support
NIH/Defense, vision related research funding
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2015
In Q2, American Academy of Ophthalmology had in-house lobbyists. The report was filed on July 15, 2015.
Original Filing: 300735493.xml
Lobbying Issues
Optometric Equity in Medicaid Act, Federal mandates for Medicaid of optometric medical & surgical coverage, all sections
SGR - Medicare Physician Payment Reform
H.R. 1707, Access to Frontline Health Care Act, all sections
H.R. 1741, Truth in Health Marketing Act, all sections
H.R. 1190, Protecting Seniors Access to Medicare Act, all sections
S. 141, Protecting Seniors Access to Medicare Act, all sections
P.L. 111-192, Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act of 2010, all sections related to physicians and vision
P.L. 111-148 Affordable Care Act, modifications:
1. Reducing regulatory/costly burdens on medical practices - relief from regulatory penalties
2. Preserving patient access to office ancillary testing services
3. Essential Benefits - Children's Vision
4. Independent Payment Advisory Board
H.R. 1312, National Health Service Corps Improvement Act
Meaningful Use/EHR program issues
P.L. 113-54, Drug Quality & Security Act, all sections
H.R. 2, Medicare Access & CHIP Reauthorization Act
Protecting Access to Medicare Act (P.L. 113-93)
ASC Quality Reporting Program
Medicare Advantage plan network adequacy
2015 Physician Schedule Rule, Issues pertaining to clinical data regional/global surgery payments
H.R. 270, FlexIT Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Lobbying Issues
Vision Center of Excellence funding/support
Caregivers and Veterans Health Services Act, Sec 601 (PL 111-163)
Provision of Vision Care within VA health systems
H.R. 1688, Legislation to grant VA residency slots to optometry
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Vision Center of Excellence funding/support
NIH/Defense, vision related research funding
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2015
In Q1, American Academy of Ophthalmology had in-house lobbyists. The report was filed on April 14, 2015.
Original Filing: 300715489.xml
Lobbying Issues
Optometric Equity in Medicaid Act, Federal mandates for Medicaid of optometric medical & surgical coverage, all sections
SGR - Medicare Physician Payment Reform
H.R. 1707, Access to Frontline Health Care Act, all sections
H.R. 1741, Truth in Health Marketing Act, all sections
H.R. 1190, Protecting Seniors Access to Medicare Act, all sections
S. 141, Protecting Seniors Access to Medicare Act, all sections
P.L. 111-192, Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act of 2010, all sections related to physicians and vision
P.L. 111-148 Affordable Care Act, modifications:
1. Reducing regulatory/costly burdens on medical practices - relief from regulatory penalties
2. Preserving patient access to office ancillary testing services
3. Essential Benefits - Children's Vision
4. Independent Payment Advisory Board
H.R. 1312, National Health Service Corps Improvement Act
Electronic Health Records Improvement Act
P.L. 113-54, Drug Quality & Security Act, all sections
H.R. 2, Medicare Access & CHIP Reauthorization Act
Protecting access to Medicare Act (P.L. 113-93)
ASC Quality Reporting Program
Medicare Advantage Participant Bill of Rights Act (S2552/HR4998), all sections
2015 Physician Schedule Rule, Issues pertaining to clinical data regional/global surgery payments
H.R. 270, FlexIT Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Lobbying Issues
Vision Center of Excellence funding/support
Caregivers and Veterans Health Services Act, Sec 601 (PL 111-163)
Provision of Vision Care within VA health systems
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Vision Center of Excellence funding/support
NIH/Defense, vision related research funding
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2014
In Q4, American Academy of Ophthalmology had in-house lobbyists. The report was filed on Jan. 20, 2015.
Original Filing: 300705611.xml
Lobbying Issues
H.R. 855 - Optometric Equity in Medicaid Act, Federal mandates for Medicaid of optometric medical & surgical coverage, all sections
SGR - Medicare Physician Payment Reform
H.R. 702, Access to Frontline Health Care Act, all sections
H.R. 1427, Truth in Health Marketing Act, all sections
H.R. 351, Protecting Seniors Access to Medicare Act, all sections
S. 351, Protecting Seniors Access to Medicare Act, all sections
P.L. 111-192, Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act of 2010, all sections related to physicians and vision
P.L. 111-148 Affordable Care Act, modifications:
1. Reducing regulatory/costly burdens on medical practices - relief from regulatory penalties
2. Preserving patient access to office ancillary testing services
3. Essential Benefits - Children's Vision
4. Independent Payment Advisory Board
H.R. 920, National Health Service Corps Improvement Act
H.R. 1331, Electronic Health Records Improvement Act
P.L. 113-54, Drug Quality & Security Act, all sections
H.R. 4015/S 2000, the SGR Repeal and Medicare Provider Payment Modernization Act
H.R. 4302, Protecting access to Medicare Act
ASC Quality Reporting Program
Medicare Advantage Participant Bill of Rights Act (S2552/HR4998), all sections
2015 Physician Schedule Rule, Issues pertaining to clinical data regional/global surgery payments
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Lobbying Issues
Vision Center of Excellence funding/support
S.1963, Caregivers and Veterans Health Services Act, Sec 601 (PL 111-163)
Provision of Vision Care within VA health systems
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Vision Center of Excellence funding/support
NIH/Defense, vision related research funding
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2014
In Q3, American Academy of Ophthalmology had in-house lobbyists. The report was filed on Oct. 19, 2014.
Original Filing: 300682283.xml
Lobbying Issues
H.R. 855 - Optometric Equity in Medicaid Act, Federal mandates for Medicaid of optometric medical & surgical coverage, all sections
SGR - Medicare Physician Payment Reform
H.R. 702, Access to Frontline Health Care Act, all sections
H.R. 1427, Truth in Health Marketing Act, all sections
H.R. 351, Protecting Seniors Access to Medicare Act, all sections
S. 351, Protecting Seniors Access to Medicare Act, all sections
P.L. 111-192, Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act of 2010, all sections related to physicians and vision
P.L. 111-148 Affordable Care Act, modifications:
1. Reducing regulatory/costly burdens on medical practices - relief from regulatory penalties
2. Preserving patient access to office ancillary testing services
3. Essential Benefits - Children's Vision
4. Independent Payment Advisory Board
H.R. 920, National Health Service Corps Improvement Act
H.R. 1331, Electronic Health Records Improvement Act
P.L. 113-54, Drug Quality & Security Act, all sections
H.R. 4015/S 2000, the SGR Repeal and Medicare Provider Payment Modernization Act
H.R. 4302, Protecting access to Medicare Act
ASC Quality Reporting Program
Medicare Advantage Participant Bill of Rights Act (S2552/HR4998), all sections
Qualified Clinical Data Registry Issues - Proposed 2015 Physician Schedule Rule
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Lobbying Issues
Vision Center of Excellence funding/support
S.1963, Caregivers and Veterans Health Services Act, Sec 601 (PL 111-163)
Provision of Vision Care within VA health systems
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Vision Center of Excellence funding/support
NIH/Defense, vision related research funding
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2014
In Q2, American Academy of Ophthalmology had in-house lobbyists. The report was filed on July 17, 2014.
Original Filing: 300658826.xml
Lobbying Issues
H.R. 855 - Optometric Equity in Medicaid Act, Federal mandates for Medicaid of optometric medical & surgical coverage, all sections
SGR - Medicare Physician Payment Reform
H.R. 702, Access to Frontline Health Care Act, all sectionsH.R. 1427, Truth in Health Marketing Act, all sections
H.R. 351, Protecting Seniors Access to Medicare Act, all sections
S. 351, Protecting Seniors Access to Medicare Act, all sections
P.L. 111-192, Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act of 2010, all sections related to physicians and vision
P.L. 111-148 Affordable Care Act, modifications:
1. Reducing regulatory/costly burdens on medical practices - relief from regulatory penalties
2. Preserving patient access to office ancillary testing services
3. Essential Benefits - Children's Vision
4. Independent Payment Advisory Board
H.R. 920, National Health Service Corps Improvement Act
H.R. 1331, Electronic Health Records Improvement Act
P.L. 113-54, Drug Quality & Security Act, all sections
H.R. 4015/S 2000, the SGR Repeal and Medicare Provider Payment Modernization Act
H.R. 4302, Protecting access to Medicare Act
ASC Quality Reporting Program
Medicare Advantage Participant Bill of Rights Act (S2552/HR4998), all sections
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS)
Lobbying Issues
Vision Center of Excellence funding/support
S.1963, Caregivers and Veterans Health Services Act, Sec 601 (PL 111-163)
Provision of Vision Care within VA health systems
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
Lobbying Issues
Vision Center of Excellence funding/support
NIH/Defense, vision related research funding
Agencies Lobbied
U.S. House of Representatives U.S. Senate
1st Quarter, 2014
In Q1, American Academy of Ophthalmology had in-house lobbyists. The report was filed on April 17, 2014.
Original Filing: 300640263.xml
Lobbying Issues
H.R. 855 - Optometric Equity in Medicaid Act, Federal mandates for Medicaid of optometric medical & surgical coverage, all sections
SGR - Medicare Physician Payment Reform
H.R. 702, Access to Frontline Health Care Act, all sectionsH.R. 1427, Truth in Health Marketing Act, all sections
H.R. 351, Protecting Seniors Access to Medicare Act, all sections
S. 351, Protecting Seniors Access to Medicare Act, all sections
P.L. 111-192, Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act of 2010, all sections related to physicians and vision
P.L. 111-148 Affordable Care Act, modifications:
1. Reducing regulatory/costly burdens on medical practices - relief from regulatory penalties
2. Preserving patient access to office ancillary testing services
3. Essential Benefits - Children's Vision
4. Independent Payment Advisory Board
H.R. 920, National Health Service Corps Improvement Act
H.R. 1331, Electronic Health Records Improvement Act
H.R. 3204, Drug Quality & Security Act, all sections
H.R. 4015/S 2000, the SGR Repeal and Medicare Provider Payment Modernization Act
H.R. 4302, Protecting access to Medicare Act
ASC Quality Reporting Program
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS)
Lobbying Issues
Vision Center of Excellence funding/support
S.1963, Caregivers and Veterans Health Services Act, Sec 601 (PL 111-163)
Provision of Vision Care within VA health systems
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
Lobbying Issues
Vision Center of Excellence funding/support
NIH/Defense, vision related research funding
Agencies Lobbied
U.S. House of Representatives U.S. Senate
4th Quarter, 2013
In Q4, American Academy of Ophthalmology had in-house lobbyists. The report was filed on Jan. 17, 2014.
Original Filing: 300619613.xml
Lobbying Issues
H.R. 855 - Optometric Equity in Medicaid Act, Federal mandates for Medicaid of optometric medical & surgical coverage, all sections
SGR - Medicare Physician Payment Reform
H.R. 702, Access to Frontline Health Care Act, all sectionsH.R. 1427, Truth in Health Marketing Act, all sections
H.R. 351, Protecting Seniors Access to Medicare Act, all sections
S. 351, Protecting Seniors Access to Medicare Act, all sections
P.L. 111-192, Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act of 2010, all sections related to physicians and vision
P.L. 111-148 Affordable Care Act, modifications:
1. Reducing regulatory/costly burdens on medical practices - relief from regulatory penalties
2. Preserving patient access to office ancillary testing services
3. Essential Benefits - Children's Vision
4. Independent Payment Advisory Board
H.R. 920, National Health Service Corps Improvement Act
H.R. 1331, Electronic Health Records Improvement Act
S. 959, Pharmaceutical Compounding Quality and Accountability Act, all sections
H.R. 3089, Compounding Clarity Act, all sections
H.R. 3204, Drug Quality & Security Act, all sections
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS)
Lobbying Issues
Vision Center of Excellence funding/support
S.1963, Caregivers and Veterans Health Services Act, Sec 601 (PL 111-163)
Provision of Vision Care within VA health systems
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
Lobbying Issues
Vision Center of Excellence funding/support
NIH/Defense, vision related research funding
Agencies Lobbied
U.S. House of Representatives U.S. Senate
3rd Quarter, 2013
In Q3, American Academy of Ophthalmology had in-house lobbyists. The report was filed on Oct. 14, 2013.
Original Filing: 300593249.xml
Lobbying Issues
H.R. 855 - Optometric Equity in Medicaid Act, Federal mandates for Medicaid of optometric medical & surgical coverage, all sections
SGR - Medicare Physician Payment Reform
H.R. 702, Access to Frontline Health Care Act, all sectionsH.R. 1427, Truth in Health Marketing Act, all sections
H.R. 351, Protecting Seniors Access to Medicare Act, all sections
S. 351, Protecting Seniors Access to Medicare Act, all sections
P.L. 111-192, Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act of 2010, all sections related to physicians and vision
P.L. 111-148 Affordable Care Act, modifications:
1. Reducing regulatory/costly burdens on medical practices - relief from regulatory penalties
2. Preserving patient access to office ancillary testing services
3. Essential Benefits - Children's Vision
4. Independent Payment Advisory Board
H.R. 920, National Health Service Corps Improvement Act
H.R. 1331, Electronic Health Records Improvement Act
S. 959, Pharmaceutical Compounding Quality and Accountability Act, all sections
H.R. 3089, Compounding Clarity Act, all sections
H.R. 3204, Drug Quality & Security Act, all sections
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS)
Lobbying Issues
Vision Center of Excellence funding/support
S.1963, Caregivers and Veterans Health Services Act, Sec 601 (PL 111-163)
Provision of Vision Care within VA health systems
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
Lobbying Issues
Vision Center of Excellence funding/support
NIH/Defense, vision related research funding
Agencies Lobbied
U.S. House of Representatives U.S. Senate
2nd Quarter, 2013
In Q2, American Academy of Ophthalmology had in-house lobbyists. The report was filed on July 16, 2013.
Original Filing: 300573002.xml
Lobbying Issues
H.R. 855 - Optometric Equity in Medicaid Act, Federal mandates for Medicaid of optometric medical & surgical coverage, all sections
SGR - Medicare Physician Payment Reform
H.R. 702, Access to Frontline Health Care Act, all sectionsH.R. 1427, Truth in Health Marketing Act, all sections
H.R. 351, Protecting Seniors Access to Medicare Act, all sections
S. 351, Protecting Seniors Access to Medicare Act, all sections
P.L. 111-192, Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act of 2010, all sections related to physicians and vision
P.L. 111-148 Affordable Care Act, modifications:
1. Reducing regulatory/costly burdens on medical practices - relief from regulatory penalties
2. Preserving patient access to office ancillary testing services
3. Essential Benefits - Children's Vision
4. Independent Payment Advisory Board
H.R. 920, National Health Service Corps Improvement Act
H.R. 1331, Electronic Health Records Improvement Act
S. 959 Pharmaceutical Compounding Quality and Accountability Act, all sections
House compounding pharmacy draft legislation
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS)
Lobbying Issues
Vision Center of Excellence funding/support
S.1963, Caregivers and Veterans Health Services Act, Sec 601 (PL 111-163)
Provision of Vision Care within VA health systems
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
Lobbying Issues
Vision Center of Excellence funding/support
NIH/Defense, vision related research funding
Agencies Lobbied
U.S. House of Representatives U.S. Senate
1st Quarter, 2013
In Q1, American Academy of Ophthalmology had in-house lobbyists. The report was filed on April 18, 2013.
Original Filing: 300553671.xml
Lobbying Issues
H.R. 855 - Optometric Equity in Medicaid Act, Federal mandates for Medicaid of optometric medical & surgical coverage, all sections
SGR - Medicare Physician Payment Reform
H.R. 702, Access to Frontline Health Care Act, all sectionsH.R. 1427, Truth in Health Marketing Act, all sections
H.R. 351, Protecting Seniors Access to Medicare Act, all sections
S. 351, Protecting Seniors Access to Medicare Act, all sections
P.L. 111-192, Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act of 2010, all sections related to physicians and vision
P.L. 111-148 Affordable Care Act, modifications:
1. Reducing regulatory/costly burdens on medical practices - relief from regulatory penalties
2. Preserving patient access to office ancillary testing services
3. Essential Benefits - Children's Vision
4. Independent Payment Advisory Board
H.R. 920, National Health Service Corps Improvement Act
H.R. 1331, Electronic Health Records Improvement Act
Compounding Pharmacy oversight
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS)
Lobbying Issues
Vision Center of Excellence funding/support
S.1963, Caregivers and Veterans Health Services Act, Sec 601 (PL 111-163)
Provision of Vision Care within VA health systems
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
Lobbying Issues
Vision Center of Excellence funding/support
NIH/Defense, vision related research funding
Agencies Lobbied
U.S. House of Representatives U.S. Senate
4th Quarter, 2012
In Q4, American Academy of Ophthalmology had in-house lobbyists. The report was filed on Jan. 18, 2013.
Original Filing: 300532940.xml
Lobbying Issues
H.R. 1219 - Optometric Equity in Medicaid Act of 2011, Federal mandates for Medicaid of optometric medical & surgical coverage, all sections
SGR - Medicare Physician Payment Reform
H.R. 531, Access to Frontline Health Care Act, all sectionsH.R. 451, Health Care Truth and Transparency Act, all sections
H.R. 452, Medicare Decisions Accountability Act, all sections
S. 668, the Health Care Bureaucrats Elimination Act, all sections
P.L. 111-192, Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act of 2010, all sections related to physicians and vision
P.L. 111-148 Affordable Care Act, modifications:
1. Reducing regulatory/costly burdens on medical practices - relief from regulatory penalties
2. Preserving patient access to office ancillary testing services
3. Essential Benefits - Children's Vision
4. Independent Payment Advisory Board
H.R. 5, Protecting Access to Healthcare Act, all sections
S. 2192/H.R. 1195, National Health Service Corps Improvement Act
H.R. 6598, Electronic Health Records Improvement Act
2013 Proposed Physician Payment Rule, Multiple Procedure Payment Reduction Policy
Compounding Pharmacy oversight
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS)
Lobbying Issues
Vision Center of Excellence funding/support
S.1963, Caregivers and Veterans Health Services Act, Sec 601 (PL 111-163)
Provision of Vision Care within VA health systems
HR 3216, the VHA Ophthalologic Service Establishment Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
Lobbying Issues
Vision Center of Excellence funding/support
NIH/Defense, vision related research funding
Agencies Lobbied
U.S. House of Representatives U.S. Senate
3rd Quarter, 2012
In Q3, American Academy of Ophthalmology had in-house lobbyists. The report was filed on Oct. 19, 2012.
Original Filing: 300525458.xml
Lobbying Issues
H.R. 1219 - Optometric Equity in Medicaid Act of 2011, Federal mandates for Medicaid of optometric medical & surgical coverage, all sections
SGR - Medicare Physician Payment Reform
H.R. 531, Access to Frontline Health Care Act, all sectionsH.R. 451, Health Care Truth and Transparency Act, all sections
H.R. 452, Medicare Decisions Accountability Act, all sections
S. 668, the Health Care Bureaucrats Elimination Act, all sections
P.L. 111-192, Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act of 2010, all sections related to physicians and vision
P.L. 111-148 Affordable Care Act, modifications:
1. Reducing regulatory/costly burdens on medical practices - relief from regulatory penalties
2. Preserving patient access to office ancillary testing services
3. Essential Benefits - Children's Vision
4. Independent Payment Advisory Board
H.R. 5, Protecting Access to Healthcare Act, all sections
S. 2192/H.R. 1195, National Health Service Corps Improvement Act
Electronic Health Records Improvement Act (draft legislation)
2013 Proposed Physician Payment Rule, Multiple Procedure Payment Reduction Policy
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS)
Lobbying Issues
Vision Center of Excellence funding/support
S.1963, Caregivers and Veterans Health Services Act, Sec 601 (PL 111-163)
Provision of Vision Care within VA health systems
HR 3216, the VHA Ophthalologic Service Establishment Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
Lobbying Issues
Vision Center of Excellence funding/support
NIH/Defense, vision related research funding
Agencies Lobbied
U.S. House of Representatives U.S. Senate
2nd Quarter, 2012
In Q2, American Academy of Ophthalmology had in-house lobbyists. The report was filed on July 19, 2012.
Original Filing: 300492969.xml
Lobbying Issues
H.R. 1219 - Optometric Equity in Medicaid Act of 2011, Federal mandates for Medicaid of optometric medical & surgical coverage, all sections
SGR - Medicare Physician Payment Reform
H.R. 531, Access to Frontline Health Care Act, all sectionsH.R. 451, Health Care Truth and Transparency Act, all sections
H.R. 452, Medicare Decisions Accountability Act, all sections
S. 668, the Health Care Bureaucrats Elimination Act, all sections
P.L. 111-192, Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act of 2010, all sections related to physicians and vision
P.L. 111-148 Affordable Care Act, modifications:
1. Reducing regulatory/costly burdens on medical practices - relief from regulatory penalties
2. Preserving patient access to office ancillary testing services
3. Essential Benefits - Children's Vision
4. Independent Payment Advisory Board
H.R. 5, Protecting Access to Healthcare Act, all sections
S. 2192/H.R. 1195, National Health Service Corps Improvement Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS)
Lobbying Issues
Vision Center of Excellence funding/support
S.1963, Caregivers and Veterans Health Services Act, Sec 601 (PL 111-163)
Provision of Vision Care within VA health systems
HR 3216, the VHA Ophthalologic Service Establishment Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
Lobbying Issues
Vision Center of Excellence funding/support
NIH/Defense, vision related research funding
Agencies Lobbied
U.S. House of Representatives U.S. Senate
1st Quarter, 2012
In Q1, American Academy of Ophthalmology had in-house lobbyists. The report was filed on April 20, 2012.
Original Filing: 300470839.xml
Lobbying Issues
H.R. 1219 - Optometric Equity in Medicaid Act of 2011, Federal mandates for Medicaid of optometric medical & surgical coverage, all sections
SGR - Medicare Physician Payment Reform
H.R. 531, Access to Frontline Health Care Act, all sectionsH.R. 451, Health Care Truth and Transparency Act, all sections
H.R. 452, Medicare Decisions Accountability Act, all sections
S. 668, the Health Care Bureaucrats Elimination Act, all sections
P.L. 111-192, Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act of 2010, all sections related to physicians and vision
P.L. 111-148 Affordable Care Act, modifications:
1. Reducing regulatory/costly burdens on medical practices - relief from regulatory penalties
2. Preserving patient access to office ancillary testing services
3. Essential Benefits - Children's Vision
4. Independent Payment Advisory Board
H.R. 5, Protecting Access to Healthcare Act, all sections
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS)
Lobbying Issues
Vision Center of Excellence funding/support
S.1963, Caregivers and Veterans Health Services Act, Sec 601 (PL 111-163)
Provision of Vision Care within VA health systems
HR 3216, the VHA Ophthalologic Service Establishment Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
Lobbying Issues
Vision Center of Excellence funding/support
NIH/Defense, vision related research funding
Agencies Lobbied
U.S. House of Representatives U.S. Senate
4th Quarter, 2011
In Q4, American Academy of Ophthalmology had in-house lobbyists. The report was filed on Jan. 20, 2012.
Original Filing: 300451734.xml
Lobbying Issues
H.R. 1219 - Optometric Equity in Medicaid Act of 2011, Federal mandates for Medicaid of optometric medical & surgical coverage, all sections
SGR - Medicare Physician Payment Reform
H.R. 531, Access to Frontline Health Care Act, all sectionsH.R. 451, Health Care Truth and Transparency Act, all sections
H.R. 452, Medicare Decisions Accountability Act, all sections
S. 668, the Health Care Bureaucrats Elimination Act, all sections
P.L. 111-192, Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act of 2010, all sections related to physicians and vision
P.L. 111-148 Affordable Care Act, modifications:
1. Reducing regulatory/costly burdens on medical practices - relief from regulatory penalties
2. Preserving patient access to office ancillary testing services
3. Essential Benefits - Children's Vision
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS)
Lobbying Issues
Vision Center of Excellence funding/support
S.1963, Caregivers and Veterans Health Services Act, Sec 601 (PL 111-163)
Provision of Vision Care within VA health systems
HR 3216, the VHA Ophthalologic Service Establishment Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
Lobbying Issues
Vision Center of Excellence funding/support
NIH/Defense, vision related research funding
Agencies Lobbied
U.S. House of Representatives U.S. Senate
3rd Quarter, 2011
In Q3, American Academy of Ophthalmology had in-house lobbyists. The report was filed on Oct. 18, 2011.
Original Filing: 300418169.xml
Lobbying Issues
H.R. 1219 - Optometric Equity in Medicaid Act of 2011, Federal mandates for Medicaid of optometric medical & surgical coverage, all sections
SGR - Medicare Physician Payment Reform
H.R. 531, Access to Frontline Health Care Act, all sectionsH.R. 451, Health Care Truth and Transparency Act, all sections
H.R. 452, Medicare Decisions Accountability Act, all sections
S. 668, the Health Care Bureaucrats Elimination Act, all sections
P.L. 111-192, Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act of 2010, all sections related to physicians and vision
P.L. 111-148 Affordable Care Act, modifications:
1. Reducing regulatory/costly burdens on medical practices - relief from regulatory penalties
2. Preserving patient access to office ancillary testing services
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
Lobbying Issues
Vision Center of Excellence funding/support
S.1963, Caregivers and Veterans Health Services Act, Sec 601 (PL 111-163)
Provision of Vision Care within VA health systems
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
Lobbying Issues
Vision Center of Excellence funding/support
NIH/Defense, vision related research funding
Agencies Lobbied
U.S. House of Representatives U.S. Senate
2nd Quarter, 2011
In Q2, American Academy of Ophthalmology had in-house lobbyists. The report was filed on July 20, 2011.
Original Filing: 300404151.xml
Lobbying Issues
H.R. 1219 - Optometric Equity in Medicaid Act of 2011, Federal mandates for Medicaid of optometric medical & surgical coverage, all sections
SGR - Medicare Physician Payment Reform
H.R. 531, Access to Frontline Health Care Act, all sectionsH.R. 451, Health Care Truth and Transparency Act, all sections
H.R. 452, Medicare Decisions Accountability Act, all sections
S. 668, the Health Care Bureaucrats Elimination Act, all sections
P.L. 111-192, Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act of 2010, all sections related to physicians and vision
P.L. 111-148 Affordable Care Act, modifications:
1. Reducing regulatory/costly burdens on medical practices - relief from regulatory penalties
2. Preserving patient access to office ancillary testing services
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
Lobbying Issues
Vision Center of Excellence funding/support
S.1963, Caregivers and Veterans Health Services Act, Sec 601 (PL 111-163)
Provision of Vision Care within VA health systems
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
Lobbying Issues
Vision Center of Excellence funding/support
NIH/Defense, vision related research funding
Agencies Lobbied
U.S. House of Representatives U.S. Senate
1st Quarter, 2011
American Academy of Ophthalmology amended a lobbying report for in-house lobbying in Q12011 on Jan. 22, 2015
Original Filing: 300709015.xml
Lobbying Issues
H.R. 1219 - Optometric Equity in Medicaid Act of 2011, Federal mandates for Medicaid of optometric medical & surgical coverage, all sections
SGR - Medicare Physician Payment Reform Act
H.R. 3590 Patient Protection and Affordable Care Act, P.L. 111-148H.R. 3962, Affordable Health Care for America Act, (PL 111-192)
H.R. 531, Access to Frontline Health Care Act
H.R. 451, Health Care Truth and Transparency Act
H.R. 452, Medicare Decisions Accountability Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
Lobbying Issues
Vision Center of Excellence funding/support
S.1963, Caregivers and Veterans Health Services Act, Sec 601 (PL 111-163)
Provision of Vision Care within VA health systems
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
Lobbying Issues
Vision Center of Excellence funding/support
NIH/Defense, vision related research funding
Agencies Lobbied
U.S. House of Representatives U.S. Senate
1st Quarter, 2011
In Q1, American Academy of Ophthalmology had in-house lobbyists. The report was filed on April 20, 2011.
Original Filing: 300379001.xml
Lobbying Issues
H.R. 1219 - Optometric Equity in Medicaid Act of 2011, Federal mandates for Medicaid of optometric medical & surgical coverage, all sections
SGR - Medicare Physician Payment Reform Act
H.R. 3590 Patient Protection and Affordable Care Act, P.L. 111-148H.R. 3962, Affordable Health Care for America Act, (PL 111-192)
H.R. 531, Access to Frontline Health Care Act
H.R. 451, Health Care Truth and Transparency Act
H.R. 452, Medicare Decisions Accountability Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
Lobbying Issues
Vision Center of Excellence funding/support
S.1963, Caregivers and Veterans Health Services Act, Sec 601 (PL 111-163)
Provision of Vision Care within VA health systems
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
Lobbying Issues
Vision Center of Excellence funding/support
NIH/Defense, vision related research funding
Agencies Lobbied
U.S. House of Representatives U.S. Senate
4th Quarter, 2010
In Q4, American Academy of Ophthalmology had in-house lobbyists. The report was filed on Jan. 20, 2011.
Original Filing: 300352190.xml
Lobbying Issues
H.R. 2697 - Optometric Equity in Medicaid Act of 2009, Federal mandates for Medicaid of optometric medical & surgical coverage, all sections
SGR - H.R. 3961, Medicare Physician Payment Reform Act, all sections
H.R. 3590 Patient Protection and Affordable Care ActH.R. 3962, Affordable Health Care for America Act
H.R. 4371, to amend Title XVIII of the Social Security Act, all sections
H. Res. 1226 /S. Res. 557, Resolution recognizing 25th Anniversary of Eye Care America Program
H.R. 577/S.259, Vision Care for Kids Act of 2009, provide vision care to children, and for other purposes, all sections
H.R. 3590, Patient Protection and Affordable Care Act
Vision and Eye Health Promotion Act (draft)
H.R. 5295, Truth in Advertising Act
H.R. 3763 /S.3416, Red Flag Guidelines Legislation
H.R. 3652/S.3737, Consistency, Accuracy, Responsibility and Excellence in Medical Imaging and Radiation Therapy Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
Lobbying Issues
Vision Center of Excellence funding/support
S.1963, Caregivers and Veterans Health Services Act, Sec 601
Provision of Vision Care within VA health systems
H.R. 6123, Veterans' Traumatic Brain Injury Rehabilitation Services Improvement Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Veterans Affairs - Dept of (VA)
Lobbying Issues
Vision Center of Excellence funding/support
NIH/Defense, vision related research funding
Agencies Lobbied
U.S. House of Representatives U.S. Senate
3rd Quarter, 2010
In Q3, American Academy of Ophthalmology had in-house lobbyists. The report was filed on Oct. 20, 2010.
Original Filing: 300326964.xml
Lobbying Issues
H.R. 2697 - Optometric Equity in Medicaid Act of 2009, Federal mandates for Medicaid of optometric medical & surgical coverage, all sections
SGR - H.R. 3961, Medicare Physician Payment Reform Act, all sections
H.R. 3590 Patient Protection and Affordable Care ActH.R. 3962, Affordable Health Care for America Act
H.R. 4371, to amend Title XVIII of the Social Security Act, all sections
H. Res. 1226 /S. Res. 557, Resolution recognizing 25th Anniversary of Eye Care America Program
H.R. 577/S.259, Vision Care for Kids Act of 2009, provide vision care to children, and for other purposes, all sections
H.R. 3590, Patient Protection and Affordable Care Act
Vision and Eye Health Promotion Act (draft)
H.R. 5295, Truth in Advertising Act
H.R. 3763 /S.3416, Red Flag Guidelines Legislation
H.R. 3652/S.3737, Consistency, Accuracy, Responsibility and Excellence in Medical Imaging and Radiation Therapy Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Vision Center of Excellence funding/support
S.1963, Caregivers and Veterans Health Services Act, Sec 601
Provision of Vision Care within VA health systems
H.R. 6123, Veterans' Traumatic Brain Injury Rehabilitation Services Improvement Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Veterans Affairs - Dept of (VA)
Lobbying Issues
Vision Center of Excellence funding/support
NIH/Defense, vision related research funding
Agencies Lobbied
U.S. House of Representatives U.S. Senate
2nd Quarter, 2010
In Q2, American Academy of Ophthalmology had in-house lobbyists. The report was filed on July 20, 2010.
Original Filing: 300297024.xml
Lobbying Issues
HR 2697 - Optometric Equity in Medicaid Act of 2009, Federal mandates for Medicaid of optometric medical & surgical coverage, all sections
SGR - HR 3961, Medicare Physician Payment Reform Act, all sections
HR 3590 Patient Protection and Affordable Care ActHR 3962 Affordable Health Care for America Act
HR 4371, to amend Title XVIII of the Social Security Act, all sections
H ReS. 1226, Resolution recognizing 25th Anniversary of Eye Care America Program
HR 577/S 259 - Vision Care for Kids Act of 2009, provide vision care to children, and for other purposes, all sections
HR 3590, Patient Protection and Affordable Care Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Vision Center of Excellence funding/support
S 1963, Caregivers and Veterans Health Services Act, Sec 601
Provision of Vision Care within VA health systems
Agencies Lobbied
U.S. House of Representatives U.S. Senate Veterans Affairs - Dept of (VA)
Lobbying Issues
Vision Center of Excellence funding/support
NIH/Defense, vision related research funding
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Enforcement of Fairness to Contact Lens Consumer Act; contact lens prescription validation
Agencies Lobbied
Food & Drug Administration (FDA)
Type of Issue
Consumer Issues/Safety/Protection
1st Quarter, 2010
In Q1, American Academy of Ophthalmology had in-house lobbyists. The report was filed on April 20, 2010.
Original Filing: 300272977.xml
Lobbying Issues
H.R. 577/S. 259 - Vision Care for Kids Act of 2009, provide vision care to children, and for other purposes, all sections
H.R. 3590, Patient Protection and Affordable Care Act (Medicare and Medicaid provisions, health plans and the exchange, National Health Service Corp, Byrd Amendment)H.R. 4371, to amend Title XVIII of the Social Security Act, all sections
SGR - H.R. 3961, Medicare Physician Payment Reform Act, all sections
H ReS. 1226, Resolution recognizing 25th Anniversary of Eye Care America Program
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Vision Center of Excellence funding/support
S. 252, Veterans Health Care Authroization, all sections
VA Health Care Quality, issues
Agencies Lobbied
U.S. House of Representatives U.S. Senate Veterans Affairs - Dept of (VA)
Lobbying Issues
NIH/Defense, vision related research funding
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Enforcement of Fairness to Contact Lens Consumer Act; contact lens prescription validation
Agencies Lobbied
Food & Drug Administration (FDA)
Type of Issue
Consumer Issues/Safety/Protection
4th Quarter, 2009
In Q4, American Academy of Ophthalmology had in-house lobbyists. The report was filed on Jan. 19, 2010.
Original Filing: 300238062.xml
Lobbying Issues
H.R. 2697 - Optometric Equity in Medicaid Act of 2007, Federal mandate for Medicaid of optometric medical & surgical coverage, all sections
H.R. 577/S. 259 - Vision Care for Kids Act of 2009, provide vision care to children, and for other purposes, all sections
Health Reform Legislation, all sections especially Medicare and MedicaidExpanding coverage under SCHIP
H.R. 2891 - Access to Frontline Health Care Act, all sections
Eye Care America - educating Members about the program
H.R. 1884 - National Health Service Corps Improvement Act, all sections
H.R. 4371 Cardiology PPIS carve out legislation
H.R. 3962 Affordable Health Care for America Act, all sections
S. 1776 SGR fix legislation, all sections
H.R. 3961 SGR fix legislation, all sections
H.R. 3590 Patient Protection & Affordable Care Act, all sections
Practice expense/CMS physician payment rule
Avastin reimbursement by CMS
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Vision Center of Excellence funding/support
S. 252 - Veterans Health Care Authorization, all sections
VA Health Care Quality, all sections
Agencies Lobbied
U.S. House of Representatives U.S. Senate Veterans Affairs - Dept of (VA)
Lobbying Issues
Vision Center of Excellence funding/support
NIH/Defense - vision related research funding
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Enforcement of Fairness to Contact Lens Consumers Act; contact lens prescription validation & FTC complaint process
Agencies Lobbied
Federal Trade Commission (FTC)
Type of Issue
Consumer Issues/Safety/Protection
3rd Quarter, 2009
In Q3, American Academy of Ophthalmology had in-house lobbyists. The report was filed on Oct. 20, 2009.
Original Filing: 300220983.xml
Lobbying Issues
H.R. 2697 - Optometric Equity in Medicaid Act of 2007, Federal mandate for Medicaid of optometric medical & surgical coverage, all sections
H.R. 577/S. 259 - Vision Care for Kids Act of 2009, provide vision care to children, and for other purposes, all sections
Health Reform Legislation, all sections especially Medicare and MedicaidExpanding coverage under SCHIP
H.R. 2891 - Access to Frontline Health Care Act, all sections
Eye Care America - educating Members about the program
H.R. 1884 - National Health Service Corps Improvement Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Vision Center of Excellence funding/support
S. 252 - Veterans Health Care Authorization, all sections
VA Health Care Quality
Agencies Lobbied
U.S. House of Representatives U.S. Senate Veterans Affairs - Dept of (VA)
Lobbying Issues
Vision Center of Excellence funding/support
NIH/Defense - vision related research funding
Agencies Lobbied
U.S. House of Representatives U.S. Senate
2nd Quarter, 2009
In Q2, American Academy of Ophthalmology had in-house lobbyists. The report was filed on July 15, 2009.
Original Filing: 300178930.xml
Lobbying Issues
H.R. 2697 - Optometric Equity in Medicaid Act of 2007, Federal mandate for Medicaid of optometric medical & surgical coverage, all sections
H.R. 577 /S.259 - Vision Care for Kids Act of 2009, provide vision care to children, and for other purposes, all sections
Health Reform Legislation, all sections especially ultraound and SGR issuesExpanding coverage under SCHIP
H.R. 2891 - Access to Frontline Health Care Act, all sections
Eye Care America - educating Members about the program
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
Lobbying Issues
Vision Center of Excellence funding
S. 252 - Veterans Health Care Authorization, all sections
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Vision Center of Excellence funding
NIH/Defense - vision related research funding
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2009
In Q1, American Academy of Ophthalmology had in-house lobbyists. The report was filed on April 21, 2009.
Original Filing: 300166074.xml
Lobbying Issues
H.R. 1 - American Recovery and Reinvestment Act of 2009 (Stimulus Bill)
H.R. 1983 - Optometric Equity in Medicaid Act of 2007, Federal mandate for Medicaid of optometric medical and surgical coverage
H.R. 577 - Vision Care for Kids Act of 2009
Vision Center of Excellence
Defense related vision research funding
NEI Appropriations
Agencies Lobbied
U.S. House of Representatives U.S. Senate
4th Quarter, 2008
In Q4, American Academy of Ophthalmology had in-house lobbyists. The report was filed on Jan. 15, 2009.
Original Filing: 300120901.xml
Lobbying Issues
S. 1117 - Vision Care for Kids Act, all sections
S. 1693 - Wired for Health Care Quality Act, all sections
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS),
Lobbying Issues
HR 1983 - Optometric Equity in Medicaid Act, all sections
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
S. 2969 - Veterans Medical Personnel Recruitment and Retention Act of 2008, all sections
HR 3558 - Military Eye Trauma Treatment Act, all sections
Agencies Lobbied
U.S. House of Representatives U.S. Senate Veterans Affairs - Dept of (VA) Food & Drug Administration (FDA)
3rd Quarter, 2008
In Q3, American Academy of Ophthalmology had in-house lobbyists. The report was filed on Oct. 20, 2008.
Original Filing: 300104138.xml
Lobbying Issues
HR 1884 - National Health Service Corps Improvement Act, all sections
S. 1117 - Vision Care for Kids Act, all sections
S. 1693 - Wired for Health Care Quality Act, all sections
HR 2012 - Contact Lens Consumer Health Protection Act, all sections
HR 2260 - The Health Care Truth and Transparency Act of 2007, all sections
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS),
Lobbying Issues
S. 3101/HR 6331 - Medicare Improvements for Patients and Providers Act of 2008, all sections; DMEPOS Competitive Bidding Requirement, all sections
HR 1983 - Optometric Equity in Medicaid Act, all sections
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
S. 2969 - Veterans Medical Personnel Recruitment and Retention Act of 2008, all sections
HR 3558 - Military Eye Trauma Treatment Act, all sections
Agencies Lobbied
U.S. House of Representatives U.S. Senate Food & Drug Administration (FDA) Veterans Affairs - Dept of (VA)
2nd Quarter, 2008
In Q2, American Academy of Ophthalmology had in-house lobbyists. The report was filed on July 14, 2008.
Original Filing: 300064460.xml
Lobbying Issues
S. 3101/HR 6331 -Medicare Improvements for Patients and Providers Act of 2008, all sections; HR 1983 Optometric Equity in Medicaid Act, all sections; HR 1884National Health Service Corps Improvement Act, all sections; S. 1117 Vision Care for Kids Act, all sections; S. 1693 Wired for Health Care Quality Act, all sections; S. 2969-Veterans Medical Personnel Recruitment and Retention Act of 2008, all sections; DMEPOS Competitive Bidding Requirement; HR 3558 Military Eye Trauma Treatment Act, all
Agencies Lobbied
U.S. House of Representatives U.S. Senate Food & Drug Administration (FDA) Centers For Medicare and Medicaid Services (CMS) Veterans Affairs - Dept of (VA)
1st Quarter, 2008
American Academy of Ophthalmology amended a lobbying report for in-house lobbying in Q12008 on July 14, 2008
Original Filing: 300064497.xml
Lobbying Issues
HR 1884 National Health Service Corps Improvement Act, all sections; HR 1983 Optometric Equity in Medicaid Act, all sections; S. 2785 Save Medicare Act of 2008, all sections; S 1117 Vision Care for Kids Act, all sections;
HR 2585 Ensuring the Future Physician Workforce Act, all sections; S. 1693 Wired for Health Care Quality Act, all sections; HR 3558 Military Eye Trauma Treatment Act, all section
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS)
1st Quarter, 2008
In Q1, American Academy of Ophthalmology had in-house lobbyists. The report was filed on April 21, 2008.
Original Filing: 300047902.xml
Lobbying Issues
HR 1884 National Health Service Corps Improvement Act, all sections; HR 1983 Optometric Equity in Medicaid Act, all sections; S. 2785 Save Medicare Act of 2008, all sections; S 1117 Vision Care for Kids Act, all sections;
HR 2585 Ensuring the Future Physician Workforce Act, all sections; S. 1693 Wired for Health Care Quality Act, all sections; HR 3558 Military Eye Trauma Treatment Act, all section
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS)
0th Quarter, 2007
In MM, American Academy of Ophthalmology had in-house lobbyists. The report was filed on Aug. 2, 2007.
Original Filing: 200044437.xml
Lobbying Issues
HR 1884 National Health Service Corps Improvement Act
HR 1983 Optometric Equity in Medicaid Act
HR 507/ S 1117, Vision Care for Kids Act
HR 2585 Ensuring the Future Physician Workforce ActHR 2260 Healthcare Truth and Transparency Act
HR 2012 Contact Lens Consumer Health Protection Act
S. 243 Medical Care Access Protection Act
Prescription Drug User Fee Legislation - compounding drug provisions
HR1823 ACS Payment Modernization Act
Agencies Lobbied
Y
Y
Centers for Medicare and Medicaid Services
Department of Health & Human Services
Food & Drug Administration
House of Representatives; United States Senate
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate